SEC Form 4 · accession 0001562180-19-000579
PALVELLA THERAPEUTICS, INC. · PVLA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Richman
Director
Period of report
Jan 25, 2019
Accepted (ET)
Jan 29, 2019 · 5:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583648
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.74 | Jan 25, 2019 | A | 6,096 | A | Jan 25, 2019 | Jan 25, 2029 | Common Stock | 6,096 | 6,096 | D |
| Stock Option (right to buy)F2 | $2.74 | Jan 25, 2019 | A | 20,000 | A | — | Jan 25, 2029 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The stock option was issued to the Reporting Person, who elected to take stock options in lieu of $10,937.50 in cash compensation for services as a director and committee member, which compensation is payable to the Reporting Person quarterly in arrears, pursuant to the Issuer's non-employee director compensation policy.
- F2The stock option will vest as to 100% of the underlying shares on January 25, 2020, subject to the Reporting Person's continued service as a director through the vesting date.